Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.

[Generation of a herpes simplex virus-permissive mouse melanoma cell line B16RHSV].

Zhuang XF, Zhou AP, Shi GL, Han XP, Li J, Zhang Y, Zhang YH, Zhang SR, Liu BL.

Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):187-91. doi: 10.3760/cma.j.issn.0253-3766.2012.03.006. Chinese.

PMID:
22780971
[PubMed - indexed for MEDLINE]
2.

Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.

Kovacs SK, Tiwari V, Prandovszky E, Dosa S, Bacsa S, Valyi-Nagy K, Shukla D, Valyi-Nagy T.

Curr Eye Res. 2009 Oct;34(10):896-904. doi: 10.3109/02713680903184250.

PMID:
19895317
[PubMed - indexed for MEDLINE]
3.

Enhanced resistance to herpes simplex virus type 1 infection in transgenic mice expressing a soluble form of herpesvirus entry mediator.

Ono E, Yoshino S, Amagai K, Taharaguchi S, Kimura C, Morimoto J, Inobe M, Uenishi T, Uede T.

Virology. 2004 Mar 15;320(2):267-75.

PMID:
15016549
[PubMed - indexed for MEDLINE]
Free Article
4.

Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D.

Sciortino MT, Medici MA, Marino-Merlo F, Zaccaria D, Giuffrè-Cuculletto M, Venuti A, Grelli S, Mastino A.

Cell Microbiol. 2008 Nov;10(11):2297-311. doi: 10.1111/j.1462-5822.2008.01212.x. Epub 2008 Aug 15.

PMID:
18671825
[PubMed - indexed for MEDLINE]
5.

Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.

Krummenacher C, Baribaud F, Ponce de Leon M, Baribaud I, Whitbeck JC, Xu R, Cohen GH, Eisenberg RJ.

Virology. 2004 May 1;322(2):286-99.

PMID:
15110526
[PubMed - indexed for MEDLINE]
Free Article
6.

A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus.

Warner MS, Geraghty RJ, Martinez WM, Montgomery RI, Whitbeck JC, Xu R, Eisenberg RJ, Cohen GH, Spear PG.

Virology. 1998 Jun 20;246(1):179-89.

PMID:
9657005
[PubMed - indexed for MEDLINE]
Free Article
7.

Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.

Watanabe D, Goshima F, Mori I, Tamada Y, Matsumoto Y, Nishiyama Y.

J Dermatol Sci. 2008 Jun;50(3):185-96. doi: 10.1016/j.jdermsci.2007.12.001. Epub 2008 Jan 15.

PMID:
18226503
[PubMed - indexed for MEDLINE]
8.

[Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].

Han LF, Qiu WM, Hu C, Wang L, Yao HX, Xiong SY, Meng M, Fang Y, Ma D.

Zhonghua Fu Chan Ke Za Zhi. 2010 Aug;45(8):603-8. Chinese.

PMID:
21029617
[PubMed - indexed for MEDLINE]
9.

Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.

Tao J, Tu YT, Huang CZ, Feng AP, Wu Q, Lian YJ, Zhang LX, Zhang XP, Shen GX.

Br J Dermatol. 2005 Oct;153(4):715-24.

PMID:
16181451
[PubMed - indexed for MEDLINE]
10.

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Montgomery RI, Warner MS, Lum BJ, Spear PG.

Cell. 1996 Nov 1;87(3):427-36.

PMID:
8898196
[PubMed - indexed for MEDLINE]
Free Article
11.

[Construction and expression of human stathmin gene eukaryotic expression vector and its effect on esophageal cancer cells].

Wang F, Wang LX, Wang RL, Fan QX, Zhao PR.

Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):179-83. Chinese.

PMID:
18756931
[PubMed - indexed for MEDLINE]
12.

Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.

Tarrant JP, Walsh MJ, Blanchard MC, Lee TD, Hoskin DW, Giacomantonio CA.

Int J Oncol. 2004 Dec;25(6):1693-9.

PMID:
15547707
[PubMed - indexed for MEDLINE]
13.

Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.

Baek H, Uchida H, Jun K, Kim JH, Kuroki M, Cohen JB, Glorioso JC, Kwon H.

Mol Ther. 2011 Mar;19(3):507-14. doi: 10.1038/mt.2010.207. Epub 2010 Oct 5.

PMID:
20924362
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Characterization of herpes virus entry mediator as a factor linked to obesity.

Bassols J, Moreno JM, Ortega F, Ricart W, Fernandez-Real JM.

Obesity (Silver Spring). 2010 Feb;18(2):239-46. doi: 10.1038/oby.2009.250. Epub 2009 Aug 13.

PMID:
19680232
[PubMed - indexed for MEDLINE]
15.

Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.

Israyelyan AH, Melancon JM, Lomax LG, Sehgal I, Leuschner C, Kearney MT, Chouljenko VN, Baghian A, Kousoulas KG.

Hum Gene Ther. 2007 May;18(5):457-73.

PMID:
17536976
[PubMed - indexed for MEDLINE]
16.

Introduction of 65 kDa antigen of Mycobacterium tuberculosis to cancer cells enhances anti-tumor effect of BCG therapy.

Hara I, Sato N, Miyake H, Muramaki M, Hikosaka S, Kamidono S.

Microbiol Immunol. 2004;48(4):289-95.

PMID:
15107539
[PubMed - indexed for MEDLINE]
17.

Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.

Ishida D, Nawa A, Tanino T, Goshima F, Luo CH, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Tsurumi T, Nishiyama Y, Kikkawa F.

Cancer Lett. 2010 Feb 1;288(1):17-27. doi: 10.1016/j.canlet.2009.06.014. Epub 2009 Jul 14.

PMID:
19604626
[PubMed - indexed for MEDLINE]
18.
19.

Amelioration of myocarditis by HVEM-overexpressing dendritic cells through induction of IL-10-producing cells.

Cai G, Wang H, Qin Q, Zhang J, Zhu Z, Liu M, Shen Q.

Cardiovasc Res. 2009 Dec 1;84(3):425-33. doi: 10.1093/cvr/cvp219. Epub 2009 Jul 1.

PMID:
19570810
[PubMed - indexed for MEDLINE]
Free Article
20.

Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry.

Whitbeck JC, Peng C, Lou H, Xu R, Willis SH, Ponce de Leon M, Peng T, Nicola AV, Montgomery RI, Warner MS, Soulika AM, Spruce LA, Moore WT, Lambris JD, Spear PG, Cohen GH, Eisenberg RJ.

J Virol. 1997 Aug;71(8):6083-93.

PMID:
9223502
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk